{"": [104, 1827, 0], "Introduction": [1828, 9432, 0], "Cells and viruses": [9442, 10544, 0], "Enzymatic deglycosylation of purified IBV": [10545, 11113, 0], "IBV infections in the presence of kifunensine": [11114, 12548, 0], "Analysis of protein expression by estern blot": [12549, 14507, 0], "Plaque reduction assays": [14508, 15178, 0], "Immunofluorescence (IF) with confocal microscopy analysis": [15179, 16791, 0], "Protein digestion": [16836, 18062, 0, 20579, 21390, 0], "Mass spectrometry: N-glycosylation mapping": [16792, 18062, 1], "NanoLC MS ESI MS/MS analysis": [18063, 19606, 0], "Bioinformatic analysis": [19607, 20537, 0], "LC MS/MS": [21391, 22694, 0], "Mass spectrometry (MS): Glycan analysis": [20538, 22694, 1], "Data analysis": [22695, 23919, 0], "Statistical analyses": [23920, 24097, 0], "Methods": [9433, 24097, 1], "Deglycosylation identifies simple and hybrid glycans on the IBV S protein": [24107, 27250, 0], "Predicted N-glycosylation site positions on the IBV S protein vary by strain": [27251, 30723, 0], "Heterogeneity exists within the glycan profile of the M41-CK S protein": [30724, 33255, 0], "Monoclonal antibody recognition is altered following treatment with kifunensine": [33256, 37348, 0], "Kifunensine affects antibody recognition late in Beau-R infection": [37349, 39858, 0], "Complex glycans are non-essential in Beau-R and M41-CK replication": [39859, 42742, 0], "Complex glycosylation is not required for in vitro virus neutralisation": [42743, 45957, 0], "Results": [24098, 45957, 1], "Discussion": [45958, 59907, 0]}